Recent research progress on the role of BCL2 in cancer and related drugs

Yubo Jianga; Yanbin Luan; Shuyan Wang; Baoyue Zhang

doi:10.1117/12.2669368

24 March 2023 Recent research progress on the role of BCL2 in cancer and related drugs

Yubo Jianga, Yanbin Luan, Shuyan Wang, Baoyue Zhang

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126115U (2023) https://doi.org/10.1117/12.2669368
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

B-cell lymphoma (Bcl-2) proteins are a family of proteins that all have Bcl-2 homologous (BH) structural domains, such as Bcl-2, Bcl-xl, Bax, Bak and Bid. most Bcl-2 proteins have four BH structural domains (BH1, BH2, BH3 and BH4) which interact with each other. Although the bcl-2 family of proteins has long been recognized as a dominant regulator of apoptosis, beginning in the late 1990s, Sierra et al. found that bcl-2 not only limited the regulation of cell death, but also played an important role in cell migration, invasion, and tumor metastasis. In order to prove this idea, the literature on bcl- 2 family proteins was reviewed to understand the effects of bcl-2 family proteins on tumour invasion and metastasis and to investigate small molecule drugs for bcl-2 and microRNAs targeting bcl-2 inhibition. This article focuses on four main aspects of the bcl family, namely the bcl-2 composition, bcl mutation sites and their effect on tumour cell invasion and metastasis, the relationship between pro-apoptotic proteins and tumours and bcl-2 small molecule resistance. Expected to provide a theoretical basis for understanding drug studies of bcl inhibition of tumor metastasis.

Citation Download Citation

Yubo Jianga, Yanbin Luan, Shuyan Wang, and Baoyue Zhang "Recent research progress on the role of BCL2 in cancer and related drugs", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126115U (24 March 2023); https://doi.org/10.1117/12.2669368

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available